Intervention Protocol

You have full text access to this OnlineOpen article

Conjugate vaccines for preventing Haemophilus influenzae type b infections in children under 5 years of age

  1. Muhammad I Nisar1,*,
  2. Fyezah Jehan1,
  3. Yasir Shafiq1,
  4. Zohra S Lassi2,
  5. Anita KM Zaidi1

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 28 FEB 2013

DOI: 10.1002/14651858.CD010377

How to Cite

Nisar MI, Jehan F, Shafiq Y, Lassi ZS, Zaidi AKM. Conjugate vaccines for preventing Haemophilus influenzae type b infections in children under 5 years of age (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD010377. DOI: 10.1002/14651858.CD010377.

Author Information

  1. 1

    Aga Khan University Hospital, Department of Paediatrics and Child Health, Karachi, Sindh, Pakistan

  2. 2

    Aga Khan University Hospital, Division of Women and Child Health, Karachi, Pakistan

*Muhammad I Nisar, Department of Paediatrics and Child Health, Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi, Sindh, 74800, Pakistan. Imran.nisar@aku.edu. nisar_imran@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 28 FEB 2013

SEARCH

References

Additional references

Adderson 2001
  • Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, et al. Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?. Pediatrics 2001;108(1):E18.
Asensi 1995
  • Asensi F, Otero MC, Perez-Tamarit D, Miranda J, Pico L, Nieto A. Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type B (Hib) via the experience of the Children’s Hospital La Fe, Valencia, Spain. Vaccine 1995;13(16):1563-6. [DOI: 0264410X9500087H [pii]]
Blanchard-Rohner 2008
  • Blanchard-Rohner G, Pollard AJ. Sustaining immunity after immunization against encapsulated bacteria. Human Vaccines 2008;4(4):309-12.
Deeks 2011
  • Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011.
Heath 1998
  • Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatric Infectious Disease Journal 1998;17(Suppl 9):117–22.
Higgins 2011a
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011.
Higgins 2011b
  • Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non-randomised studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: Wiley-Blackwell, 2011.
Ladhani 2011
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011.
Mahoney 1999
Mangtani 2010
  • Mangtani P, Mulholland K, Madhi SA, Edmond K, O'Loughlin R, Hajjeh R. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine 2009;28:1677-83.
McConnell 2007
  • McConnell A, Tan B, Scheifele D, Halperin S, Vaudry W, Law B, et al. Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centres, 1996–2001. Pediatric Infectious Disease Journal 2007;26(11):1025-31.
Morris 2008
Peltola 1992
  • Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992;340(8819):592-4. [: 0140-6736(92)92117-X [pii]]
Peltola 2000
  • Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews 2000;13(2):302-17.
RevMan 2011
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Swingler 2007
UNAIDS 2012
  • Global report: UNAIDS report on the global AIDS epidemic 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf 2012 (accessed on 30 November 2012).
von Gottberg 2012
  • von Gottberg A, Cohen C, Whitelaw A, Chhagan M, Flannery B, Cohen AL, et al. Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine 2011;30:565-71.
Watt 2009
  • Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009;374(9693):903–11.
WHO 2002
  • Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case fatality rates. http://www.who.int/vaccines-documents/DocsPDF02/www696.pdf 2002.
WHO 2005
  • World Health Organization. Haemophilus influenzae type B (HiB): fact sheet no 294. http://www.who.int/immunization_delivery/new_vaccines/HibFactsheet_05.pdf 2005 (accessed 25 February 2012).
WHO 2006
  • WHO. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiological Record 2006;81:445–52.